European drug regulators Friday recommended approval of gene therapy Glybera for patients with a rare genetic disorder.
WSJ.com: What's News US, Wall Street Journal
Fri, 07/20/2012 - 9:40am
European drug regulators Friday recommended approval of gene therapy Glybera for patients with a rare genetic disorder.